4C Medical Technologies Closes 35M Series C Financing

4C Medical Technologies

4C Medical Technologies has raised $35M Series C funding, a Minneapolis-based medical technology company.

The round was led by MicroPort CardioFlow Medtech Corporation (HKEX:2160).

The company plans to use these funds to further develop AltaValve TMVR tech and highlight its distinctive design as well as to expand patient care using the company’s streamlined procedures.

Led by newly appointed President & Chief Executive Officer Saravana Kumar, PhD, and Dr. Jeff Chambers, Founder and Chairman of the Board, 4C Medical is a medical device company developing minimally invasive technologies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. Subject to regulatory approvals, the company’s AltaValve would be MR treatment with atrial-only fixation that is designed to minimize known issues associated with current TMVR technologies, which use placement and fixation within the native mitral annulus.

Get latest news from African Startup ecosystem

Latest stories

You might also like...